Fluticasone Propionate HFA-134a Pressurized Metered-Dose Inhaler in Adolescents and Adults with Moderate to Severe Asthma.

Autor: Pinnas, Jacob L., Noonan, Michael J., Weinstein, Steven F., Chervinsky, Paul, Scott, Catherine A., Herje, Nancy E., Wu, Wei, Crim, Courtney
Předmět:
Zdroj: Journal of Asthma; Dec2005, Vol. 42 Issue 10, p865-871, 7p, 2 Charts, 3 Graphs
Abstrakt: In this randomized, double-blind, placebo-controlled trial, 397 patients with moderate to severe asthma, previously treated with bronchodilators alone, received fluticasone propionate 88, 220, or 440 μg twice daily, or placebo via metered dose inhaler (MDI) for 12 weeks. Mean change from baseline to endpoint in pre-dose percent predicted forced expiratory volume in one second (FEV 1 ) was greater ( p [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index